Symbol: |
CYP2A13
|
Description: |
cytochrome P450, family 2, subfamily A, polypeptide 13 [Source:HGNC Symbol;Acc:2608]
|
Location: |
Chr19:41594368-41602099[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:154
Gene |
Compound |
Gen_sig |
Exp_pattern |
CYP2A13 |
NSC 674717 |
0.029 |
Up |
CYP2A13 |
5-Hydroxy-7-amino(1,2,3)thiadiazole[5,4-d]pyrimidine |
0.027 |
Up |
CYP2A13 |
NSC 676579 |
0.009 |
Down |
CYP2A13 |
NSC 676872 |
0.032 |
Up |
CYP2A13 |
NSC 677194 |
0.025 |
Up |
CYP2A13 |
NSC 677636 |
0.034 |
Up |
CYP2A13 |
16.beta.-N-methylpiperazino-5-androstene-3.beta.,17.beta.-diol |
0.006 |
Up |
CYP2A13 |
Methanone, (tricyclo[3.3.1.1(3,7)]decan-1-yl) [3-(3-nitrophenyl)-2-oxiranyl]- |
0.009 |
Up |
CYP2A13 |
5-Hydroxy-3,7-dimethoxy-3',4'-methylenedioxyflavone |
0.031 |
Up |
CYP2A13 |
Benzoic acid, 2-[(4,6-dimethyl-1-oxo-2-indanylidene) methyl]-5-methyl-, methyl ester |
0.034 |
Up |
CYP2A13 |
NSC 679073 |
0.006 |
Up |
CYP2A13 |
Z(OMe)-Gly-Ala-Phe-OBzl |
0.038 |
Up |
CYP2A13 |
NSC 680399 |
0.047 |
Up |
CYP2A13 |
1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline,methionine deriv. |
0.026 |
Up |
CYP2A13 |
NSC 681743 |
0.033 |
Down |
Expression pattern: Sensitivity / Resistance
Total:11 Current:6
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:7
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:22
Total:2 Current:1
[First] [Prev]  Next Last 
|